Apricus Biosciences Provides Corporate Update and First Quarter 2017 Financial Results
Vitaros U.S. NDA Re-Submission Remains on Track for Third Quarter 2017 Vitaros Drug-Device Human Factor Studies Underway Operations Funded Through the Third Quarter of 2018 Conference Call / Webcast Today, May 11, 2017 at 4:30 p.m. ET SAN DIEGO, May 11, …